[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Ranitidine
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Ranitidine is an anti-histamine that acts on the H2 histamine receptor, but was withdrawn from sale in the United States in 2020.[1] Ranitidine is used to treat and prevent ulcers in the stomach and intestines, to treat gastroesophageal reflux disease (GERD), and to reduce stomach acid in Zollinger-Ellison syndrome. It is sold under the brand name Zantac.[1]
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Rantidine was withdrawn from sale in the US in 2020 due to safety issues, after a cancer-causing impurity was found to be present at in many rantidine products.[1]
Costs and availability[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- Rantidine - drugs.com
- Rantidine - MedlinePlus
- Rantidine - WebMD
- 2019, Popular heartburn drug ranitidine recalled: What you need to know and do - Harvard Health Publishing
